| 9/1/2010 |
ELITE PHARMACEUTICALS ANNOUNCES ACQUISITION OF GENERIC NALTREXONE PRODUCT
|
| 8/17/2010 |
Elite Pharmaceuticals, Inc. Reports Financial Results for the
First Quarter of Fiscal 2011
…Operating loss reduced by 89%; Positive operating cash flow
|
| 8/10/2010 |
Elite Pharmaceuticals, Inc. to Discuss First Quarter Results of Operations on Tuesday, August 17, 2010
|
| 7/2/2010 |
Elite Pharmaceuticals, Inc. Announces 2010 Fourth Quarter and Year-End Investor Conference Call on Thursday, July 8, 2010
|
| 6/30/2010 |
ELITE ANNOUNCES SETTLEMENT OF LITIGATION
|
| 5/24/2010 |
ELITE PHARMACEUTICALS ANNOUNCES ACQUISITION OF GENERIC HYDROMORPHONE PRODUCT
|
| 2/22/2010 |
Elite Pharmaceuticals, Inc. 3rd Quarter 2010 Financial Results
…Revenue increased 287% for the comparable period of the prior year
|
| 2/16/2010 |
Elite Pharmaceuticals, Inc. To Host Quarterly Conference Call
on Friday, February 19, 2010
|
| 12/2/2009 |
ELITE PHRAMACEUTALS AND THEPHARMANETWORK ANNOUNCE FDA APPROVAL FOR GENERIC METHADONE TABLETS
|
| 11/16/2009 |
Elite Pharmaceuticals, Inc. To Host Quarterly Conference Call on Wednesday, November 18, 2009
|
